Cargando…
Respiratory syncytial virus‐associated acute respiratory illness in adult non‐immunocompromised patients: Outcomes, determinants of outcomes, and the effect of oral ribavirin treatment
BACKGROUND: Respiratory syncytial virus (RSV) is an increasingly common cause of respiratory illness in adult non‐immunocompromised patients. Oral ribavirin was reported to improve outcomes of RSV infection in immunocompromised patients. This study aimed to determine the outcomes of non‐immunocompro...
Autores principales: | Wongsurakiat, Phunsup, Sunhapanit, Siwadol, Muangman, Nisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178057/ https://www.ncbi.nlm.nih.gov/pubmed/35150065 http://dx.doi.org/10.1111/irv.12971 |
Ejemplares similares
-
Bacterial Coinfection and Superinfection in Respiratory Syncytial Virus-Associated Acute Respiratory Illness: Prevalence, Pathogens, Initial Antibiotic-Prescribing Patterns and Outcomes
por: Wongsurakiat, Phunsup, et al.
Publicado: (2023) -
Successful Treatment of Respiratory Syncytial Virus Infection in an Immunocompromised Patient With Ribavirin
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021) -
RIBAVIRIN AND RESPIRATORY SYNCYTIAL VIRUS
Publicado: (1986) -
Clinical manifestations and outcomes of respiratory syncytial virus infection in adult hospitalized patients
por: Chuaychoo, Benjamas, et al.
Publicado: (2019) -
Clinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children
por: Chu, Helen Y., et al.
Publicado: (2016)